In patients with type 2 diabetes, sildenafil (Viagra) improves flow-mediated dilatation (FMD), an index of nitric oxide-dependent endothelial function, according to a recent report.
Read More »Diabetes In Control
Issue 125 Item 2 Repaglinide Versus Metformin in Combination With Bedtime NPH
Combined with bedtime NPH insulin, metformin provides superior glycemic control to repaglinide.
Read More »Issue 122 Item 9 Antioxidant Vitamins Helpful in Diabetic Ketoacidosis Treatment
Administering antioxidant vitamins during treatment of diabetic ketoacidosis may minimize oxidative stress and associated complications.
Read More »Issue 124 Item 8 Seniors Pumping Iron To Control Diabetes
High-intensity weight training coupled with a moderate weight-loss program can help older men and women with type 2 diabetes to improve their blood sugar control and also boost their muscle strength and lean body mass, researchers report.
Read More »Issue 126 Item 6 FDA Approves New Indication for Glucovance
Glucovance OK’ed to use with Thiazolidediones, which makes it a triple therapy.
Read More »Issue 121 Item 15 EASD: Resistance Training Improves Glycemic Control in Elderly
Effect is not maintained if the program continues in a home-based environment, without supervision.
Read More »Issue 123 Item 14 Researchers Zero In on Foot Problems in Diabetics
Changes that take place in the tissue and bone structure of the feet of people with diabetes have been identified by researchers at the Washington University School of Medicine in St. Louis.
Read More »Issue 125 Item 12 Type 2 Diabetes Is Associated With Myocardial Insulin Resistan
Type 2 diabetes is specifically associated with myocardial insulin resistance.
Read More »Issue 121 Item 4 New Report Emphasizes Activity Over Calorie Restriction
Panel Urges Doubling Exercise from 30 minutes to 60 minutes a day and eating ‘Healthy’ Fats. The message is to Eat Less and Move More.
Read More »Eli Lilly Cuts Deal for the Rights to a New Diabetes Drug from
Eli Lilly & Company will pay up to $325 million to Amylin Pharmaceuticals, a biotechnology company based in San Diego, for the rights to a potentially promising treatment for diabetes.
Read More »
Diabetes In Control. A free weekly diabetes newsletter for Medical Professionals. News and information for Medical Professionals.